Logos Global Management as of Dec. 31, 2022
Portfolio Holdings for Logos Global Management
Logos Global Management holds 40 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ideaya Biosciences (IDYA) | 8.3 | $71M | 3.9M | 18.17 | |
| Apellis Pharmaceuticals (APLS) | 8.2 | $70M | 1.4M | 51.71 | |
| Cytokinetics Com New (CYTK) | 8.1 | $69M | 1.5M | 45.82 | |
| Immunovant (IMVT) | 6.6 | $56M | 3.2M | 17.75 | |
| Allakos (ALLK) | 5.2 | $45M | 5.3M | 8.42 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 5.0 | $43M | 1.4M | 29.60 | |
| Xenon Pharmaceuticals (XENE) | 4.2 | $36M | 900k | 39.43 | |
| Iveric Bio | 3.8 | $32M | 1.5M | 21.41 | |
| Karuna Therapeutics Ord | 3.5 | $30M | 150k | 196.50 | |
| Miragen Therapeutics (VRDN) | 3.4 | $29M | 1.0M | 29.21 | |
| Design Therapeutics (DSGN) | 3.4 | $29M | 2.8M | 10.26 | |
| Immunocore Hldgs Ads (IMCR) | 3.3 | $29M | 500k | 57.07 | |
| Sarepta Therapeutics (SRPT) | 3.3 | $29M | 220k | 129.58 | |
| Alx Oncology Hldgs (ALXO) | 3.1 | $27M | 2.3M | 11.27 | |
| Dyne Therapeutics (DYN) | 2.9 | $25M | 2.2M | 11.59 | |
| Akero Therapeutics (AKRO) | 2.6 | $22M | 400k | 54.80 | |
| Ventyx Biosciences (VTYX) | 2.5 | $22M | 657k | 32.79 | |
| Arcutis Biotherapeutics (ARQT) | 2.4 | $21M | 1.4M | 14.80 | |
| Dice Therapeutics | 2.4 | $21M | 660k | 31.20 | |
| Madrigal Pharmaceuticals (MDGL) | 2.0 | $17M | 60k | 290.25 | |
| Rocket Pharmaceuticals (RCKT) | 1.7 | $15M | 750k | 19.57 | |
| Fulcrum Therapeutics (FULC) | 1.7 | $15M | 2.0M | 7.28 | |
| Astria Therapeutics (ATXS) | 1.5 | $13M | 865k | 14.89 | |
| Cogent Biosciences (COGT) | 1.5 | $13M | 1.1M | 11.56 | |
| Geron Corporation (GERN) | 1.1 | $9.7M | 4.0M | 2.42 | |
| Olema Pharmaceuticals (OLMA) | 1.1 | $9.2M | 3.7M | 2.45 | |
| Fibrogen (FGEN) | 1.0 | $8.4M | 525k | 16.02 | |
| Cerevel Therapeutics Hldng I (CERE) | 1.0 | $8.2M | 260k | 31.54 | |
| Cymabay Therapeutics | 0.9 | $7.8M | 1.3M | 6.27 | |
| Anaptysbio Inc Common (ANAB) | 0.9 | $7.7M | 250k | 30.99 | |
| Reata Pharmaceuticals Cl A | 0.8 | $6.8M | 180k | 37.99 | |
| Vera Therapeutics Cl A (VERA) | 0.6 | $5.5M | 285k | 19.35 | |
| Prometheus Biosciences | 0.6 | $5.5M | 50k | 110.00 | |
| Rapt Therapeutics (RAPT) | 0.5 | $4.0M | 200k | 19.80 | |
| Morphosys Sponsored Ads (MOR) | 0.4 | $3.2M | 900k | 3.58 | |
| Vigil Neuroscience (VIGL) | 0.3 | $2.4M | 188k | 12.50 | |
| Spruce Biosciences (SPRB) | 0.1 | $1.1M | 1.0M | 1.10 | |
| Tyra Biosciences (TYRA) | 0.1 | $843k | 111k | 7.60 | |
| Lianbio Sponsored Ads (LIANY) | 0.1 | $459k | 280k | 1.64 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $9.6k | 67k | 0.14 |
